Johnson & Johnson (NYSE: JNJ)—the massive multinational healthcare and pharmaceutical conglomerate—generates annual revenues scaling well over $85 billion. This immense financial footprint is powered by massive global sales across its innovative pharmaceutical medicines and advanced medical technology device sectors.